Mesothelioma

Clinical Trials

Below is a list of Mesothelioma clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Phase 2 Study of GW786034 (Pazopanib) in Patients with Malignant Pleural Mesothelioma
The purpose of this research study is to find out what effects, good and/or bad, pazopanib
(GW786034) has on a patient and their disease of mesothelioma. GW786034 is an investigational agent that inhibits angiogensis, which is a new blood vessel formation.

Angiogenesis may be important in the development and progression of MPM. The research staff will also find out if there are individual differences and/or tumor characteristics that will affect response to treatment.

The drug used in this study is considered investigational, which means it has not been approved by the U.S. Food and Drug Administration (FDA) for routine clinical use described in this study. However the FDA has allowed the use of this drug in this research study.
Read more